From July 1, 2023 to September 30, 2023, the company has repurchased 3,139,400 shares, representing 0.85% for ¥4,087.94 million. With this, the company has completed the repurchase of 8,809,300 shares, representing 2.36% for ¥11,124.4 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,632 JPY | +5.43% | +6.74% | +16.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.16% | 3.62B | |
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+17.21% | 239B | |
+8.01% | 204B | |
-7.53% | 198B | |
+8.62% | 168B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.